Put companies on watchlist
DXC Technology
ISIN: US23355L1061
WKN: A2DM8U
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

DXC Technology · ISIN: US23355L1061 · PR Newswire (ID: 20240818DC77052)
18 August 2024 10:00PM

DXC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that DXC Technology Company Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!


NEW YORK, Aug. 18, 2024 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DXC Technology Company ("DXC" or "the Company") (NYSE: DXC) and certain of its officers.

Class Definition

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired DXC securities between May 26, 2021, and May 16, 2024, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/DXC.

Case Details

The complaint alleges throughout the Class Period, the Company misrepresented its ongoing "transformation journey" and the Company's ability to integrate previously acquired companies and business systems. The complaint continues to allege that while touting its ongoing success in implementing that integration, DXC repeatedly stressed its commitment to reducing the Company's restructuring and transaction, separation, and integration ("TSI") costs in order to increase its free cashflow and "unleash [its] true earnings power." In truth, Defendants knew or recklessly disregarded that the Company was only able to reduce its restructuring and TSI costs by limiting its integration efforts. As a result of Defendants' misrepresentations, shares of DXC common stock traded at artificially inflated prices throughout the Class Period. DXC also announced it would need to spend an additional $250 million to achieve the restructuring and integration process it falsely claimed to have been successfully implementing during the Class Period. These disclosures caused the price of DXC common stock to decline nearly 17%, from $19.88 per share to $16.52 per share.

What's Next?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/DXC or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. If you suffered a loss in DXC you have until October 1, 2024, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Nathan Miller

332-239-2660 | info@bgandg.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dxc-investor-alert-bronstein-gewirtz--grossman-llc-announces-that-dxc-technology-company-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-302215207.html

SOURCE Bronstein, Gewirtz & Grossman, LLC

Visual performance / price development - DXC Technology
Smart analysis and research tools can be found here.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2024
PR Newswire
Contact:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942